Diffusion and perfusion MRI predicts response preceding and shortly after radiosurgery to brain metastases: A pilot study Journal Article


Authors: Shah, A. D.; Konar, A. S.; Paudyal, R.; Oh, J. H.; LoCastro, E.; Nuñez, D. A.; Swinburne, N.; Vachha, B.; Ulaner, G. A.; Young, R. J.; Holodny, A. I.; Beal, K.; Shukla-Dave, A.; Hatzoglou, V.
Article Title: Diffusion and perfusion MRI predicts response preceding and shortly after radiosurgery to brain metastases: A pilot study
Abstract: BACKGROUND AND PURPOSE: To determine the ability of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to predict long-term response of brain metastases prior to and within 72 hours of stereotactic radiosurgery (SRS). METHODS: In this prospective pilot study, multiple b-value DWI and T1-weighted DCE-MRI were performed in patients with brain metastases before and within 72 hours following SRS. Diffusion-weighted images were analyzed using the monoexponential and intravoxel incoherent motion (IVIM) models. DCE-MRI data were analyzed using the extended Tofts pharmacokinetic model. The parameters obtained with these methods were correlated with brain metastasis outcomes according to modified Response Assessment in Neuro-Oncology Brain Metastases criteria. RESULTS: We included 25 lesions from 16 patients; 16 patients underwent pre-SRS MRI and 12 of 16 patients underwent both pre- and early (within 72 hours) post-SRS MRI. The perfusion fraction (f) derived from IVIM early post-SRS was higher in lesions demonstrating progressive disease than in lesions demonstrating stable disease, partial response, or complete response (q =.041). Pre-SRS extracellular extravascular volume fraction, ve, and volume transfer coefficient, Ktrans, derived from DCE-MRI were higher in nonresponders versus responders (q =.041). CONCLUSIONS: Quantitative DWI and DCE-MRI are feasible imaging methods in the pre- and early (within 72 hours) post-SRS evaluation of brain metastases. DWI- and DCE-MRI-derived parameters demonstrated physiologic changes (tumor cellularity and vascularity) and offer potentially useful biomarkers that can predict treatment response. This allows for initiation of alternate therapies within an effective time window that may help prevent disease progression. © 2020 American Society of Neuroimaging
Keywords: treatment response; stereotactic radiosurgery; dce-mri; brain metastases; dwi
Journal Title: Journal of Neuroimaging
Volume: 31
Issue: 2
ISSN: 1051-2284
Publisher: Wiley Blackwell  
Date Published: 2021-03-01
Start Page: 317
End Page: 323
Language: English
DOI: 10.1111/jon.12828
PUBMED: 33370467
PROVIDER: scopus
PMCID: PMC8005428
DOI/URL:
Notes: Article -- Export Date: 3 May 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gary Ulaner
    146 Ulaner
  2. Robert J Young
    228 Young
  3. Kathryn Beal
    221 Beal
  4. Akash Deelip Shah
    19 Shah
  5. Amita Dave
    137 Dave
  6. Jung Hun Oh
    187 Oh
  7. Andrei Holodny
    206 Holodny
  8. Behroze Adi Vachha
    28 Vachha
  9. Ramesh Paudyal
    38 Paudyal